FDA Approval Activities for this Drug
Raplon (rapacuronium bromide) Injection,100 mg/5 mL, 200 mg/10 mL Vial. Organon, Inc NDA 20-984 8/18/99 9/24/99 9/24/99 7/2/01
Raplon Indications: Indicated for outpatients and inpatients as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures.